Time
|
Duration
|
Type
|
Presenting person
|
Title
|
September 20th, Thursday |
|
09:00 |
Sesja 11: Molekularne mechanizmy działania leków |
09:01 |
Powitanie i wprowadzenie – Barbara Gawrońska-Szklarz |
09:05 |
00:25:00 |
Wykład |
Barbara Gawronska-Szklarz |
Pharmacogenetics: an opportunity for a safer and more efficient pharmacotherapy |
09:30 |
00:20:00 |
Wykład |
Marek Droździk |
Clinical Application of Pharmacogenetic Studies |
09:50 |
00:20:00 |
Wykład |
Monika Białecka |
Molecular aspects of central nervous system drug interactions |
10:10 |
00:25:00 |
Wykład |
Władysława A. Daniel |
Interactions of psychotropic drugs with cytochrome P450 during long-term treatment: the involvement of different mechanisms |
10:35 |
00:25:00 |
Wykład |
Zofia Mazerska |
Metabolic transformations of antitumor agents with cytochrome P-450 isoenzymes |
11:00 |
Przerwa |
11:20 |
00:25:00 |
Wykład |
Przemysław Ł. Mikołajczak |
Neurobiological basis for the treatment of alcoholism |
11:45 |
00:25:00 |
Wykład |
Franciszek K. Główka |
Molecular mechanisms of activity of stereoisomers of non-steroidal anti-inflammatory drugs |
12:10 |
00:25:00 |
Wykład |
Przemysław M. Mrozikiewicz |
Molecular Mechanisms in Phytotherapy |
12:35 |
00:20:00 |
Wykład |
Marcin Ożarowski |
Molecular aspects of herbal medicinal products activity and interactions with synthetic drugs on the central nervous system level |
12:55 |
00:15:00 |
Wykład |
Radosław Kujawski |
Investigation of the molecular mechanisms of action of natural herbal drugs in benign prostate hyperplasia |
13:10 |
00:25:00 |
Wykład |
Vyacheslav U. Buko |
Effects of promising antifibrotics in thioacetamide-induced liver fibrosis reversal |
13:35 |
00:20:00 |
Wykład |
Witold Szaflarski |
The antibiotic kasugamycin mimics mRNA nucleotides to destabilize tRNA binding and inhibit canonical translation initiation |
13:55 |
00:20:00 |
Wykład |
Hubert Wojtasek |
Application of a hydrazine linker in construction of tyrosinase-activated anti-melanoma prodrugs |
14:15 |
Podsumowanie Sesji |
14:30 |
Sesja plakatowa |
14:30 |
#P11.1 |
Poster |
Ewa Augustin |
The cellular response of human hepatoma cells with different expression of cytochrome P450 isoenzymes to treatment with acridine derivatives |
14:30 |
#P11.2 |
Poster |
Agnieszka Chrapkowska |
Imidazoacridinone antitumor agent, C-1311, as a selective mechanism-based inactivator of human recombinant cytochrome P450 1A2. |
14:30 |
#P11.3 |
Poster |
Jakub Drożak |
Differential action of gatifloxacin on the rate of glucose formation in isolated rabbit kidney-cortex tubules |
14:30 |
#P11.4 |
Poster |
Violetta E. Dziedziejko |
C677T and A1298C MTHFR polymorphisms affect arechin treatment outcome in rheumatoid arthritis |
14:30 |
#P11.5 |
Poster |
Magdalena Gorny |
Allosteric human prostatic acid phosphatase |
14:30 |
#P11.6 |
Poster |
Justyna Jakubowska |
STI571 (imatinib) and doxorubicin induction of erythroid differentiation and apoptosis in CML cell line K562 is accompanied by Δψm dissipation |
14:30 |
#P11.7 |
Poster |
Ewa Karna |
Butyrate-induced collagen biosynthesis in cultured fibroblasts is independent on α2β1 integrin signalling and undergoes through IGF-I receptor cascade |
14:30 |
#P11.8 |
Poster |
Agnieszka B. Knopik-Skrocka |
Nystatin-induced changes of mammalian erythrocyte membrane permeability in the presence of mono- and disaccharides |
14:30 |
#P11.9 |
Poster |
Joanna Koprowska |
Effects on cell cycle distribution and induction of apoptosis of human breast carcinoma MCF7 cells by imidazoacridinone C-1311 |
14:30 |
#P11.10 |
Poster |
Oxana Lukivskaya |
Ursodeoxycholic acid prevents mitochondrial dysfunction in the liver of rats with alloxan diabetes |
14:30 |
#P11.11 |
Poster |
Agnieszka Marczak |
The combined effect of daunorubicin and glutaraldehyde on the red blood cells (RBCs) membrane proteins |
14:30 |
#P11.12 |
Poster |
Zbigniew Muszczyński |
Paracetamol metabolism in black-and-white and black-and-white x holstein-friesian cross breed calves |
14:30 |
#P11.13 |
Poster |
Dorota Nowak |
The cellular response of human colon carcinoma HCT116 cells to 4-methyl-1-nitroacridine derivative C-1748 treatment depending on p53 status. |
14:30 |
#P11.14 |
Poster |
Yury E. Razvodovsky |
Taurine and BCAA can prevent ethanol-induced imbalance in the pool of free amino acids of heart |
14:30 |
#P11.15 |
Poster |
Aneta K. Rogalska |
Induction of apoptosis and necrosis in A549 and HepG2 cells by aclarubicin |
14:30 |
#P11.16 |
Poster |
Maria Rybczyńska |
The influence of lipophilic flavones of Primula veris on proliferation of HL60 cells overexpressing MRP |
14:30 |
#P11.17 |
Poster |
Michał Sabisz |
Genetic inactivation and chemical inhibition of PARP-1 leads to increased cytotoxicity to antitumor triazoloacridone C-1305 |
14:30 |
#P11.18 |
Poster |
Aleksander S. Sochanik |
Combined anticancer therapy using antivascular peptide and folate-targeted liposomes carrying doxorubicin |
14:30 |
#P11.19 |
Poster |
Anita Wiśniewska |
The role of Cytochrome P450 Reductase in metabolism of potent nitroacridine antitumor agent, C‑1748. |